  See all
 |
Articles: Drug Approvals |
Prior Articles
FDA actions in brief, September 2009 (Saphris, Tracleer, Livalo, Tyvaso, Tekturna HCT, Onsolis, Forteo, Invega Sustenna, Colcrys, Acuvail, Lipsovir, Kogenate FS)
Formulary, 09/17/09
Free full text
ImmunoGen Announces Amgen has Licensed Rights to Use the Companys TAP Technology for a Solid Tumor Target
ImmunoGen, Inc., 09/17/09
Free full text
Development and use of methylnaltrexone, a peripherally acting opioid antagonist, to treat side effects related to opioid use
Drug Development Research, 09/16/09 U.S. FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine
Sanofi-aventis, 09/16/09
Free full text
Abbott Receives European Approval for Once-Daily Dosing of Kaletra Tablet
Abbott, 09/15/09 FDA Accepts for Filing Mylans ANDA for Generic CopaxoneÂ
Mylan, 09/15/09 Abbott Announces Approval in China for Next-Generation XIENCE V Drug Eluting Stent
Abbott, 09/15/09 Trabectedin: an anticancer drug from the sea
Expert Opinion in Pharmacotherapy, 09/14/09 Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
PLoS ONE - Cardiovascular Disorders, 09/14/09 CryoLife Announces First Clinical Use of BioFoam
Cryolife, 09/11/09
Free full text
Astellas receives FDA approval for use of progr (tacrolimus) in conjunction with mycophenolate mofetil (mmf) in kidney transplant recipients
Astellas, 09/11/09
Free full text
Synthon announces European approvals for generic Rivastigmine
Synthon, 09/11/09
Free full text
Par Pharmaceutical Receives Final Approval To Market Generic Starlix
Par Pharmaceutical, 09/11/09 Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Free full text
FDA Advisory Committee Recommends Approval for Use of GARDASIL in Boys and Men
Merck & Co., 09/10/09
Free full text
Electronic Safety Reporting May Soon Be Mandatory, says FDA
Pharmaceutical Technology, 09/09/09
Free full text
Novel evidence-based systemic lupus erythematosus (sle) responder index described in peer reviewed publication as potentially significant advance in lupus drug development
Human Genome Sciences, 09/08/09
Free full text
Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOSÂ for the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals North America, 09/08/09 AstraZeneca announces FDA acceptance of New Drug Application for VIMOVO
AstraZeneca, 09/04/09
Free full text
MabThera approved in Europe for use in patients with previously-treated chronic lymphocytic leukaemia
Roche, 09/04/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
168 Available Pages
|
|
